ArticlePloS one2018

Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?

Hyeong Dong Yuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.